UK small-cap RNS · 13 Oct 2026
Every announcement of UK small & mid caps under £2bn. The ones that started or moved a situation are marked – a click opens it.
| Date | Company | Mcap | Holder | Stake | Crossed | |
|---|---|---|---|---|---|---|
| 13 Oct | Arecor Therapeutics AREC | £37m | John Lucius Arthur Cary | 8.02% → 7.78% | ||
| 13 Oct | Mears Group MER | £322m | FIL Limited | 10.07% → 10.07% | ||
| 13 Oct | Applied Nutrition Plc APN | £735m | UBS Group AG-Investment Bank & Global Wealth Management | 5.21% → 0% | 5% | |
| 13 Oct | Gamma Communications GAMA | £974m | UBS Group AG-Investment Bank & Global Wealth Management | 5.72% → 0% | 5% | |
| 13 Oct | LendInvest LINV | £41m | ATOMICO IV L.P. | 11.54% → 4.38% | 10% | |
| 13 Oct | Cerillion CER | £207m | JPMorgan Asset Management Holdings Inc. | 7.53% → 5.3% |
Notifications of major holdings (TR-1): a holder crossing 3%, 5%, 10% … of the voting rights. Key shows stakes of 5% and more; the 3–5% band (mostly index funds) is under All. Transfers inside a group are left out.